Stefan Octavian Ciurea
Associate Professor
Department of Stem Cell Transplantation and Cellular Therapy
MD Anderson Cancer Center
United States of America
Biography
Degree-Granting Education: 1996 :Gr. T. Popa University of Medicine and Pharmaceuticals, Iasi, ROM, MD, Medicine. Postgraduate Training: 2007-2008 :Clinical Fellowship, Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX. 2004-2007 :Clinical Fellowship, Hematology-Oncology, University of Illinois at Chicago College of Medicine, Chicago, IL. 2000-2003 :Clinical Residency, Internal Medicine, PennState University/PinnacleHealth at Harrisburg Hospital, Harrisburg, PA.
Research Interest
Mismatched related donors are a potential source of stem cells for virtually all patients who lack a matched sibling or unrelated donor. Expanding the use of stem cells from mismatched relatives by identifying barriers against successful transplantation, optimizing conditioning regimens, separating the graft-versus-tumor effect from graft-versus-host disease and incorporating novel strategies to enhance anti-tumor immunity, like the use of cellular therapy, represents a priority of my research.
Publications
-
Kanate AS, Mussetti A, Kharfan-Dabaja MA, Ahn KW, DiGilio A, Beitinjaneh A, Chhabra S, Fenske TS, Freytes C, Gale RP, Ganguly S, Hertzberg M, Klyuchnikov E, Lazarus HM, Olsson R, Perales MA, Rezvani A, Riches M, Saad A, Slavin S, Smith SM, Sureda A, Yared J, Ciurea S, Armand P, Salit R, Bolaños-Meade J, Hamadani M. Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched unrelated donors. Blood 127 (7) :938-47, 2016.
-
Bayraktar UD, Milton DR, Guindani M, Rondon G, Chen J, Al-Atrash G, Rezvani K, Champlin R, Ciurea SO. Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation. Biol Blood Marrow Transplant 22 (3) :505-13, 2016.
-
Brammer JE, Khouri I, Gaballa S, Anderlini P, Tomuleasa C, Ahmed S, Ledesma C, Hosing C, Champlin RE, Ciurea SO. Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning. Biol Blood Marrow Transplant 22 (3) :493-8, 2016.
